Nerve growth factor receptors in dementia
Background/aim: Nerve growth factor (NGF) promotes the survival and differentiation of sensory and sympathetic neurons. Several studies have found that certain neuropathological factors stimulate NGF receptor expression and release the truncated nerve growth factor receptor (TNGFR) to biological fluids. The aim of this pilot study was to determine urine TNGFR levels in patients with dementia and to verify whether TNGFR can be used as a biomarker of dementia. Materials and methods: Twelve patients with dementia and 12 healthy individuals were asked to voluntarily participate in this study. Ages, sexes, and weights were matched. The first morning urine samples were collected and the concentrations of TNGFR in the urine samples were measured by fluoroimmunoassay. Results: The mean levels of TNGFR in the urine samples of the healthy control subjects and the patients with dementia were 164 ± 23 and 341 ± 66 ng / mg creatinine respectively. A positive relationship was found between the levels of TNGFR in different ages of both control and patient subgroups. This is consistent with the previous observations that pathological condition may stimulate the NGF receptor expression. Conclusion: These findings might be of assistance to evaluate the development of the memory loss associated with Alzheimer disease and other age-associated diseases.
Nerve growth factor receptors in dementia
Background/aim: Nerve growth factor (NGF) promotes the survival and differentiation of sensory and sympathetic neurons. Several studies have found that certain neuropathological factors stimulate NGF receptor expression and release the truncated nerve growth factor receptor (TNGFR) to biological fluids. The aim of this pilot study was to determine urine TNGFR levels in patients with dementia and to verify whether TNGFR can be used as a biomarker of dementia. Materials and methods: Twelve patients with dementia and 12 healthy individuals were asked to voluntarily participate in this study. Ages, sexes, and weights were matched. The first morning urine samples were collected and the concentrations of TNGFR in the urine samples were measured by fluoroimmunoassay. Results: The mean levels of TNGFR in the urine samples of the healthy control subjects and the patients with dementia were 164 ± 23 and 341 ± 66 ng / mg creatinine respectively. A positive relationship was found between the levels of TNGFR in different ages of both control and patient subgroups. This is consistent with the previous observations that pathological condition may stimulate the NGF receptor expression. Conclusion: These findings might be of assistance to evaluate the development of the memory loss associated with Alzheimer disease and other age-associated diseases.
___
- Kenchappa RS, Tep C, Korade Z, Urra S, Bronfman FC. p75 neurotrophin receptor-mediated apoptosis in sympathetic neurons involves a biphasic activation of JNK and up- regulation of tumor necrosis factor-α-converting enzyme/ ADAM17. J Biol Chem 2010; 285: 20358–20368.
- Samuel AS, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. Nerve growth factor in Alzheimer’s disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 1995, 15: 6213–6221.
- Shepheard SR, Chataway T, Schultz DS, Rush RA, Rogers ML. The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis. PLoS One 2014; 9: e87398.
- Ferri CC, Moore FA, Bisby MA. Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor. J Neurobiol 1998; 34: 1–9.
- DiStefano PS, Clagett-Dame M, Chelsea DM, Loy R. Developmental regulation of human truncated nerve growth factor receptor. Ann Neurol 1991; 29: 13–20.
- Barrett GL. The p75 neurotrophin receptor and neuronal apoptosis. Prog Neurobiol 2000; 61: 205–229.
- Messripour M, Moein S. Indirect quenching fluororeceptor assay of anti-AChR antibodies. Mol Chem Neuropathol 1997; 31: 43–51.
- Landon J, Moffat AC. The radioimmunoassay of drugs. A review. Analyst 1976; 101: 225–243.
- Ouchterlong Q. Antigen-antibody reactions in gel. Acta Pathol Mic Sc 1949; 26: 507–515.
- Lindner MD, Gordon DD, Miller JM, Tariot PN, McDaniel KD, Hamill RW, DiStefano PS, Loy R. Increased levels of truncated nerve growth factor receptor in urine of mildly demented patients with Alzheimer’s disease. Arch Neurol 1993; 50: 1054– 1058.